Podcast: Michael Johnson, Rhinomed
About the author:
- Author name:
- By Scott Power
- Job title:
- Senior Analyst
- Date posted:
- 05 July 2016, 4:08 PM
- Sectors Covered:
- Healthcare, Life Sciences
I recently caught up with the CEO of Rhinomed, Michael Johnson. Rhinomed has innovative nasal technology which increases airflow through the nose benefitting both athletes (the turbine) and those people who snore at night (the mute).
Michael tells us that the products are selling well through a number of distribution outlets around the world including BOOTS in the UK and Walgreens in the US.
More information
Morgans clients can login to view our latest detailed report for Rhinomed (RNO). Alternatively, please contact your nearest Morgans office for access.
Disclaimer(s): Analyst owns shares
The information contained in this report is provided to you by Morgans Financial Limited as general advice only, and is made without consideration of an individual's relevant personal circumstances. Morgans Financial Limited ABN 49 010 669 726, its related bodies corporate, directors and officers, employees, authorised representatives and agents (“Morgans”) do not accept any liability for any loss or damage arising from or in connection with any action taken or not taken on the basis of information contained in this report, or for any errors or omissions contained within. It is recommended that any persons who wish to act upon this report consult with their Morgans investment adviser before doing so.
-
Print this page
-
Copy Link